Ricardo Lleonart

AFLP polymorphisms allow high resolution genetic analysis of American Tegumentary Leishmaniasis agents circulating in Panama and other members of the Leishmania genus.

The genome of Leishmania panamensis: insights into genomics of the L. (Viannia) subgenus.

Genome-wide discovery and development of polymorphic microsatellites from Leishmania panamensis parasites circulating in central Panama.

Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.

Use of AFLP for the study of eukaryotic pathogens affecting humans.

Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.

Antiviral Activity of Novel Quinoline Derivatives against Dengue Virus Serotype 2.

VianniaTopes: a database of predicted immunogenic peptides for Leishmania (Viannia) species.

Hexahydropyrrolo[2,3-]indole Compounds as Potential Therapeutics for Alzheimer's Disease.

Environmental Conditions May Shape the Patterns of Genomic Variations in .

Genomes: How Genomic Information has been Used to Deal with Past Outbreaks and the COVID-19 Pandemic.

Antileishmanial activity of a new chloroquine analog in an animal model of Leishmania panamensis infection.

Morphological and molecular characterization supporting Amblyomma mixtum presence in Cuba.

HLA allele and haplotype frequencies in the Panamanian population.

Gene expression patterns associated with Leishmania panamensis infection in macrophages from BALB/c and C57BL/6 mice.

Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama.

Development of in-house, indirect ELISAs for the detection of SARS-CoV-2 spike protein-associated serology in COVID-19 patients in Panama.

Genomic diversity and genetic variation of Leishmania panamensis within its endemic range.